News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Demonstrating Discontent, May 21, 1990
Andrea Anderson | Jul 17, 2017
Activists demanded greater access to and involvement in clinical research for AIDS treatments—and their protests were heard.
Study: New Test Can Unearth Elusive HIV
Aggie Mika | May 29, 2017
The assay screens for latent virus that has the capacity to activate if antiretroviral therapy stops.
HIV Vaccines May Help Tamp Down Virus
Kerry Grens | Feb 24, 2017
A fraction of HIV patients in a small, uncontrolled study were able to stop antiretroviral therapy after receiving the immune boosters.
Unique Antibodies Open Path Toward New HIV Vaccines
Amanda B. Keener | Jan 27, 2017
A family of broadly neutralizing antibodies from a chronically infected donor provides a schematic for designing vaccines and treatments that target multiple strains of the virus.
Antibody Shows Promise For Combatting Diverse Strains Of HIV
Joshua A. Krisch | Nov 17, 2016
In preclinical trials, the N6 antibody neutralized 98 percent of 181 HIV strains tested.
USB Stick Rapidly Detects HIV
Joshua A. Krisch | Nov 15, 2016
The prototype blood test could eventually be used to diagnose infections in resource-poor regions.
Five Oncoviruses Debut On NIH Carcinogen List
Joshua A. Krisch | Nov 7, 2016
Seven newly evaluated substances, including five oncoviruses, have been added to the US National Institutes of Health’s 14th Report on Carcinogens.
Week in Review: October 24–28
Bob Grant | Oct 27, 2016
Patient Zero exonerated; Jack Woodall dies;
-harboring mosquitoes deployed in fight against Zika; implanted neurons function in adult mouse brain
HIV Spread from Haiti to NYC in 1970, “Patient Zero” Not to Blame
Ben Andrew Henry | Oct 26, 2016
Whole-genome sequencing of preserved blood samples provides the clearest picture to date of the virus’s arrival and spread in the U.S.
Broadly Neutralizing Antibodies in HIV Patients
Jef Akst | Sep 28, 2016
Researchers identify aspects of the patient, the virus, and the infection itself that influence whether a person with HIV will produce broadly neutralizing antibodies.